Kyntra Bio, Inc. (KYNB)

Kyntra Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	37	47.87	50.48	81.55	155.7	171.22
Short-Term Investments	50.24	41.11	-	121.9	266.31	233.97
Cash & Short-Term Investments	87.24	88.98	50.48	203.45	422.01	405.19
Cash Growth	159.56%	76.26%	-75.19%	-51.79%	4.15%	-40.98%
Accounts Receivable	5.04	0.22	0.48	5.12	16.3	17.4
Inventory	3.38	3.74	3.16	17.17	40.44	31.02
Other Current Assets	5.69	6.14	142.39	105.81	14.08	20.45
Total Current Assets	101.36	99.07	196.51	331.56	492.83	474.06
Net Property, Plant & Equipment	-	-	-	69.72	100.5	119.39
Long-Term Investments	8.03	20.16	-	-	9.41	171.62
Other Long-Term Assets	0.25	0.36	18.02	22.25	7.35	8.75
Total Assets	109.63	119.59	214.53	423.53	610.09	773.82

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.09	3.75	5.06	15.78	30.76	26.1
Accrued Expenses	17.34	20.18	62.04	132.99	219.77	172.6
Current Portion of Leases	-	-	-	12.65	10.29	10.94
Unearned Revenue	5.68	5.31	27.29	12.74	12.74	15.86
Other Current Liabilities	-	-	38.92	43.52	-	-
Total Current Liabilities	28.11	29.24	133.31	217.67	273.56	225.5
Long-Term Debt	67.41	65.98	131.96	123.35	49.33	-
Long-Term Leases	-	-	-	65.03	79.59	88.78
Other Long-Term Liabilities	23.4	19.9	132.9	179.68	209.08	230.44
Total Long-Term Liabilities	90.81	85.88	264.85	368.06	338.01	319.21
Total Liabilities	118.92	115.12	398.16	585.73	611.57	544.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	1.01	1.01	0.99	0.94	0.93
Additional Paid-in Capital	1,679	1,677	1,669	1,644	1,541	1,476
Accumulated Other Comprehensive Income	-1.89	-2.18	-5.73	-6.88	-5.72	-4.16
Retained Earnings	-1,721	-1,706	-1,889	-1,842	-1,558	-1,264
Total Common Shareholders' Equity	-43.8	-30.04	-225.6	-204.17	-21.45	209.15
Minority Interest	34.51	34.51	41.97	41.97	19.97	19.97
Shareholders' Equity	-9.29	4.48	-183.64	-162.2	-1.48	229.11
Total Liabilities & Equity	109.63	119.59	214.53	423.53	610.09	773.82

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	67.41	65.98	131.96	201.03	139.22	99.72
Net Cash (Debt)	19.83	23	-81.47	2.42	282.79	305.47
Net Cash Growth	-	-	-	-99.14%	-7.42%	-52.77%
Net Cash Per Share	4.90	5.69	-20.36	0.62	75.55	82.69
Book Value	-43.8	-30.04	-225.6	-204.17	-21.45	209.15
Book Value Per Share	-10.83	-7.43	-56.37	-52.46	-5.73	56.62
Tangible Book Value	-43.8	-30.04	-225.6	-204.17	-21.45	209.15
Tangible Book Value Per Share	-10.83	-7.43	-56.37	-52.46	-5.73	56.62

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error